A case report in AME Case Reports by Yun Xiao, Zhourui Liu, and Sha Li of the Department of Ultrasound at Guizhou Medical University, China, documents a rare case of synovial sarcoma arising directly in the pulmonary artery, a location so uncommon that it was initially mistaken for a benign cardiac tumor. What the Case […]
Closing the AYA Gap: Clinical Trials, Genetic Testing, and Palliative Care for Young Sarcoma Patients
A new educational review in the American Society of Clinical Oncology Educational Book, authored by Sophie Jessop, MBBS, and colleagues, examines three persistent gaps in care for adolescents and young adults (AYAs) with sarcoma: clinical trial access, genetic testing for inherited cancer risk, and timely palliative care. The piece is grounded by the firsthand perspective […]
Then and Now: Decoding the Chromatin Machinery Behind Synovial Sarcoma
A new profile by Mariella Bodemeier Loayza Careaga, PhD, published in The Scientist, revisits biochemist Cigall Kadoch’s research nearly a decade after the publication first covered her work, tracing how her lab has continued to map the molecular hijacking that drives synovial sarcoma. The BAF Complex and the SS18-SSX Fusion Kadoch’s research centers on BAF […]
When Synovial Sarcoma Hides in Plain Sight: A Diagnostic Wake-Up Call
A case report published in Frontiers in Oncology by Miyazaki, Oike, and colleagues at Niigata University Graduate School of Medical and Dental Sciences, Japan, documents a rare synovial sarcoma presentation that defeated every standard diagnostic test – and delayed correct treatment by over three years. The case carries urgent lessons for patients, advocates, and clinicians […]
Study Finds Tumor Size and Surgical Margins are Key Drivers of Synovial Sarcoma Outcomes
A new multi-center retrospective study from three major U.S. sarcoma centers has analyzed outcomes in patients with localized synovial sarcoma, making it one of the largest modern cohorts to examine how tumor characteristics and treatment modality affect recurrence and survival in this disease. The study, led by Stefano Testa, Maggie Yuxi Zhou, and colleagues from […]
Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis
Synovial sarcoma is a rare and aggressive soft tissue cancer that most often develops near the joints of the arms or legs. In very rare cases, however, it can appear in unusual locations — including the skull and brain region. A newly published case report describes a patient diagnosed with primary cranial synovial sarcoma who […]
New Research Identifies 4 Subtypes of Synovial Sarcoma, Opening Doors for Personalized Treatment
Synovial sarcoma is a rare and aggressive soft tissue cancer, but new research is helping us better understand how it behaves—and how it may be treated in the future. A recent study using advanced single-cell RNA sequencing has identified four distinct subtypes of synovial sarcoma, each with unique biological features and potential treatment pathways. Why […]
What a Breakthrough in Ewing Sarcoma Means for Synovial Sarcoma
A new Phase 1/2 trial in Ewing sarcoma, just profiled in Clinical Trial Vanguard and published in Nature Medicine, delivered the kind of result the synovial sarcoma community should be watching closely. The trial paired trabectedin with low-dose irinotecan to target the EWS::FLI1 fusion, the oncogenic driver of Ewing sarcoma. For more than a decade, […]
Rare Tumor Mimics Synovial Sarcoma: Why Accurate Diagnosis Matters
A recent case report highlights a rare GLI1-altered mesenchymal tumor presenting in the pleura (lining of the lung), a location where tumors can closely resemble synovial sarcoma. This case underscores a critical challenge in rare cancers — different tumors can appear similar under imaging and even under the microscope, making accurate diagnosis essential for appropriate […]
Cell Therapies for Synovial Sarcoma: Afami-cel (Tecelra)
Advances in cell therapy for synovial sarcoma are creating more treatment options for patients with advanced disease. A recent update from Penn Medicine highlights the growing role of T-cell therapies in treating rare cancers like synovial sarcoma. What Is Afami-cel? Afamitresgene autoleucel (afami-cel) is the first FDA-approved T-cell receptor (TCR) therapy for adults with advanced […]










